PCSK9 inhibition: an important step forward in treating dyslipidemia in high-risk patients.
Topic:
Lipids
Sponsored by Amgen
Event:
ESC Congress 2015
Congress Presentation
Access the full session
About the event
ESC 365 is supported by
